SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nel ASA (NLLSY) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 25/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NLLSY
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.45
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-20.40
Book Value / Share$0.00
Revenue / Share$15.53
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-2.45 |
$98.45M |
$-55.83M |
-56.7% |
| 2017 |
$-1.83 |
$286.37M |
$-52.45M |
-18.3% |
| 2018 |
$-5.40 |
$453.19M |
$-188.83M |
-41.7% |
| 2019 |
$-6.60 |
$519.05M |
$-269.71M |
-52% |
| 2020 |
$27.30 |
$578.33M |
$1.26B |
218.2% |
| 2021 |
$-34.20 |
$753.1M |
$-1.67B |
-221.3% |
| 2022 |
$-22.80 |
$914.85M |
$-1.17B |
-128% |
| 2023 |
$-15.60 |
$1.68B |
$-855.2M |
-50.9% |
| 2024 |
$-4.50 |
$1.39B |
$-244.34M |
-17.6% |
| 2025 |
$-20.40 |
$935.1M |
$-1.23B |
-131.4% |
